SAN DIEGO -- (BUSINESS WIRE) -- SynteractHCR, a full-service, international contract research organization (CRO), is presenting and exhibiting at the Drug Information Association (DIA) 2014 50th Annual Meeting June 16-19 at the San Diego Convention Center. The company will exhibit at booth #1731, where a team of its own international experts will speak on trending topics important to the biopharma industry and provide answers to issues impacting the efficiencies and speed of clinical trials.
With numerous questions surrounding the increasingly complex drug development process, SynteractHCR’s theme for DIA 2014 is: “We have your answers.” SynteractHCR experts are prepared to discuss sponsor project needs and how the company can support all aspects of international, phase I-IV programs. SynteractHCR will also have its own recruitment professionals present to discuss career openings at the company, particularly in the area of medical, regulatory and drug safety, project management, clinical operations, and quality assurance.
“As we approach this important industry event, our sights remain clearly focused on client collaboration, communication and service excellence,” says SynteractHCR CEO Wendel Barr. “We have been a trusted clinical trial outsourcing partner to clients for many years because of our ability to provide clear advice, clear data, clear results, and overall, clear answers. We are pleased that key members of our global clinical development team will share their expertise and guidance in person during DIA in San Diego, the city where we are headquartered.”
Specific speaker presentations include:
To make an appointment in advance, please contact Matt Smith, SVP Business Development, at 760-268-8200 or Matt.Smith@SynteractHCR.com. The company will also post live updates from DIA on Twitter @SynteractHCR and by using #DIA2014answers. Visit www.synteractHCR.com/DIA2014 for more information and to sign up to receive SynteractHCR experts’ presentations after DIA 2014.
About SynteractHCR (www.synteracthcr.com)
SynteractHCR is a full-service contract research organization with a successful two-decade track record supporting biotechnology, medical device, and pharmaceutical companies in all phases of clinical development. SynteractHCR has conducted Phase I-IV studies on six continents and in more than 50 countries, offering expertise across multiple therapeutic areas and with notable depth in oncology, CNS, infectious disease, endocrinology, cardiovascular, and respiratory, among other indications. With its “Shared Work – Shared Vision” philosophy and ICD+ approach, SynteractHCR provides customized services collaboratively and cost effectively, ensuring on-time delivery of quality data so clients get to decision points faster.